32/41
Progress report (1)
Reviews continue to be generic, not specific
nPanel I: “A generic recommendation relied on the accumulated evidence and indicates the status of information about the substance. A recommendation for a company’s licensed product was based upon information which applies to that product alone.” (50 FR 3084)
nMost of Panel I’s reviews were “generic”
nA few were product-specific
nfor example, Dermatophytin (Hollister Stier) and Histamine Azoprotein (Parke Davis)
n
n